A detailed history of Ensign Peak Advisors, Inc transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 605,536 shares of VIGL stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
605,536
Previous 395,116 53.26%
Holding current value
$1.17 Million
Previous $1.58 Million 30.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.92 - $4.65 $614,426 - $978,453
210,420 Added 53.26%
605,536 $2.06 Million
Q2 2024

Aug 13, 2024

BUY
$2.51 - $4.66 $417,769 - $775,619
166,442 Added 72.79%
395,116 $1.58 Million
Q4 2023

Feb 14, 2024

BUY
$2.97 - $8.6 $643,747 - $1.86 Million
216,750 Added 1817.76%
228,674 $772,000
Q3 2023

Nov 13, 2023

BUY
$4.8 - $9.92 $57,235 - $118,286
11,924 New
11,924 $64,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $54.6M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.